Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update

Go back to Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update
GALECTIN (NASDAQ: GALT) Delayed: 4.14 -0.47 (10.2%)
Previous Close $4.61    52 Week High $3.05 
Open $4.60    52 Week Low $0.49 
Day High $4.65    P/E N/A 
Day Low $4.10    EPS $-1.32 
Volume 393,346